EODData

MEMBERSHIP REGISTER LOG IN

FRA, F6T: Fate Therapeutics Inc

18 Aug 2026
LAST:

2.204

CHANGE:
 0.05		OPEN:
2.160		HIGH:
2.204		ASK:
0.000		VOLUME:
45
CHG(%):
2.51		PREV:
2.150		LOW:
2.160		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Aug 262.1602.2042.1602.20445
17 Aug 262.1502.1502.1502.1500
14 Aug 262.1062.1062.1062.1060
13 Aug 262.2842.2842.2842.2840
12 Aug 262.3022.3022.3022.3020
07 Aug 262.0842.0842.0842.0840
06 Aug 262.1862.1862.1862.1860
05 Aug 262.1782.1782.1782.1780
04 Aug 262.1122.1122.1122.1120
03 Aug 262.0862.0862.0862.0860

PROFILE

Name:Fate Therapeutics Inc
About:Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Website:https://www.fatetherapeutics.com
ISIN:US31189P1021
LEI:549300L14Q4UHOODLA90

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.27 
Forward P/E:-0.99 
PEG Ratio:0.12 
Price to Sales:48.24 
Price to Book:1.93 
Operating Margin:-25.40 
Return on Assets:-0.25 
Return on Equity:-0.56 
Revenue:5.53M 
Shares:115.33M 
Market Cap:254.19M 

TECHNICAL INDICATORS

MA5:2.210.2%
MA10:2.171.6%
MA20:2.171.4%
MA50:2.104.9%
MA100:1.7526.3%
MA200:1.3761.1%
STO9:55.05
STO14:71.35
RSI14:54.34
WPR14:-28.66
MTM14:0.16
ROC14:0.08 
ATR:0.09 
Week High:2.304.4%
Week Low:2.114.7%
Month High:2.408.8%
Month Low:1.9661.1%
Year High:2.6721.0%
Year Low:0.79179.0%
Volatility:47.81